Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fufang Yinhua detoxification granules vs Lianhua Qingwen in COVID-19
ChiCTR2200066613Phase 4Not yet recruiting
- Sponsor
- Yixing People's Hospital
- Start
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of fufang yinhua jiedu in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by Yixing People's Hospital. Primary endpoint: Time between initial administration and recovery of clinical symptoms. Planned start Dec 2022; status: not yet recruiting.
02
Drugs
fufang yinhua jiedu
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on ChiCTR2200066613.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200066613.